Rchr
J-GLOBAL ID:201801013564327576
Update date: Oct. 01, 2022
Numajiri Haruko
Numajiri Haruko
Affiliation and department:
-
About -
Search "-"
Detailed information
Research field (2):
Tumor diagnostics and therapeutics
, Radiology
Papers (31):
Nobuyoshi Fukumitsu, Kazunori Nitta, Toshiyuki Terunuma, Toshiyuki Okumura, Haruko Numajiri, Yoshiko Oshiro, Kayoko Ohnishi, Masashi Mizumoto, Teruhito Aihara, Hitoshi Ishikawa, et al. Registration error of the liver CT using deformable image registration of MIM Maestro and Velocity AI. BMC MEDICAL IMAGING. 2017. 17
Masashi Mizumoto, Shigeyuki Murayama, Tetsuo Akimoto, Yusuke Demizu, Takashi Fukushima, Yuji Ishida, Yoshiko Oshiro, Haruko Numajiri, Hiroshi Fuji, Toshiyuki Okumura, et al. Long-term follow-up after proton beam therapy for pediatric tumors: a Japanese national survey. CANCER SCIENCE. 2017. 108. 3. 444-447
Kuniaki Fukuda, Toshiyuki Okumura, Masato Abei, Nobuyoshi Fukumitsu, Kazunori Ishige, Masashi Mizumoto, Naoyuki Hasegawa, Haruko Numajiri, Kayoko Ohnishi, Hitoshi Ishikawa, et al. Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma. CANCER SCIENCE. 2017. 108. 3. 497-503
Masashi Mizumoto, Shigeyuki Murayama, Tetsuo Akimoto, Yusuke Demizu, Takashi Fukushima, Yuji Ishida, Yoshiko Oshiro, Haruko Numajiri, Hiroshi Fuji, Toshiyuki Okumura, et al. Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan. CANCER MEDICINE. 2016. 5. 7. 1519-1525
Nobuyoshi Fukumitsu, Toshiyuki Okumura, Daichi Takizawa, Hirokazu Makishima, Haruko Numajiri, Keiko Murofushi, Kayoko Ohnishi, Masashi Mizumoto, Teruhito Aihara, Hitoshi Ishikawa, et al. Proton beam therapy for metastatic liver tumors. RADIOTHERAPY AND ONCOLOGY. 2015. 117. 2. 322-327
more...
Professional career (1):
博士(医学) (筑波大学)
Association Membership(s) (2):
JAPAN RADIOLOGICAL SOCIETY
, JAPANESE SOCIETY FOR RADIATION ONCOLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM